You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 21, December 3, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Epilepsy
 •Surgery
 •Surgical Interventions
 •Neurosurgery
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Surgical Treatment for Epilepsy

Too Little, Too Late?

Jerome Engel Jr, MD, PhD

JAMA. 2008;300(21):2548-2550.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Epilepsy is one of the most common serious neurological conditions. According to a study by the World Health Organization, epilepsy accounts for 1% of the global burden of disease based on disability-adjusted life-years (DALYs), productive years lost due to disability or premature death.1 This is equivalent to lung cancer in men and breast cancer in women. Among primary disorders of the brain, epilepsy ranks with depression and other affective disorders, Alzheimer disease and other dementias, and substance abuse. Of the world's population, 0.5% to 1.0% has active epilepsy, and pharmacotherapy is unsuccessful in controlling seizures in 20% to 40% of patients.2 In the United States, 80% of the cost of epilepsy is attributable to patients with medically intractable seizures.3 Temporal lobe epilepsy is the most common cause of pharmacoresistant seizures4 and may constitute half or more of the patients in the United States with medically . . . [Full Text of this Article]

Author Affiliations: Departments of Neurology, Neurobiology, and Psychiatry and Biobehavioral Sciences, and the Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

A 24-Year-Old Woman With Intractable Seizures: Review of Surgery for Epilepsy
and
JAMA. ;300():2527-2538.
FULL TEXT  

Epilepsy Surgery for Pharmacoresistant Temporal Lobe Epilepsy: A Decision Analysis
, , , , , , and
JAMA. ;300():2497-2505.
FULL TEXT  

Epilepsy Surgery
, , and
JAMA. ;300():2568-2568.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Surgical Treatment for Epilepsy in Developing Countries--Reply
Schomer and Black
JAMA 2009;301:1769-1770.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.